SEC Form 4 · accession 0001203311-17-000078
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vaughn B Himes
Officer — Chief Technical Officer
Period of report
Sep 8, 2017
Accepted (ET)
Sep 12, 2017 · 7:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 8, 2017 | M | 6,836 | $12.16 | A | 171,742 | D | |
| Common StockF3,F1 | Sep 8, 2017 | S | 6,836 | $53.45 | D | 164,906 | D | |
| Common StockF1 | Sep 8, 2017 | M | 3,164 | $9.23 | A | 168,070 | D | |
| Common StockF4,F1 | Sep 8, 2017 | S | 3,164 | $52.72 | D | 164,906 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F5 | $9.23 | Sep 8, 2017 | M | 3,164 | D | — | Apr 30, 2019 | Common Stock | 3,164 | 0 | D |
| Non-Qualified Stock Option (right to buy)F6 | $12.16 | Sep 8, 2017 | M | 6,836 | D | — | Aug 25, 2019 | Common Stock | 6,836 | 9,831 | D |
Explanation of responses
- F1Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F3Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $53.09 to $53.92. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F4Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $52.55 to $53.09. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F5Shares vested at a rate of 25% on 4/30/2010 and monthly thereafter until all the shares are fully vested on 4/30/2013.
- F6Shares vested at a rate of 25% on 8/25/2010 and monthly thereafter until all the shares are fully vested on 8/25/2013.